Methods of treatment for cholestatic and fibrotic diseases
AssigneeGenfit
InventorsRaphael Darteil, Robert Walczak, Carole Belanger, Emilie Negro, Pierre Daubersies, Philippe Delataille
Life of this patent
Estimating the term…
Abstract
The present invention relates to the compound [2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl]ethanoate (Nitazoxanide) or 2-hydroxy-N-(5-nitro-2-thiazolyl)benzamide (Tizoxanide) for treating cholestatic and fibrotic diseases.
Claims10
A method for treating intestinal fibrosis comprising administering to a subject in need thereof a therapeutic effective amount of a compound selected in the group consisting of Nitazoxanide (NTZ), Tizoxanide (TZ), and a pharmaceutically acceptable salt of NTZ or TZ.
A method for treating intestinal fibrosis comprising administering to a subject in need thereof a therapeutic effective amount of nitazoxanide.
Dependencies are inferred from the claim text.